Company Overview of Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. provides clinical-stage research and development services. It focuses on cancer supportive care and gastroenterology. The company was formerly known as Sapphire Therapeutics, Inc. and changed its name to Helsinn Therapeutics (U.S.), Inc. in January 2009. The company was founded in 2000 and is based in Bridgewater, New Jersey. As of January 28, 2009, Helsinn Therapeutics (U.S.), Inc. operates as a subsidiary of Helsinn Healthcare S.A.
1140 US Highway 22
Bridgewater, NJ 08807
Founded in 2000
Key Executives for Helsinn Therapeutics (U.S.), Inc.
Similar Private Companies By Industry
|SFBC New Drug Services, Inc.||United States|
|Xcovery LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
|Santalis Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Helsinn Therapeutics (U.S.), Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.